Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Field&flower are a trusted retailer of ethical meat, fish and cheese. They provide grass fed, free range meat boxes to over 4500 active subscription customers. They were profitable in 16/17 with a revenue of £2.7m and are now looking to expand and become a major online food retailer.
days to go:
Expired
investment:
£877,030
Brickowner aims to become the leading service provider for property developers and asset managers, ensuring benefits for both parties. The company undertakes background checks of investors on its portal for the benefit of asset managers. It also ensures that investors can easily navigate its portal and find deals that suit their financial appetite. Brickowner successfully exited five investment rounds despite two investments happening in the wake of COVID-19. The platform has over 3,000 investors registered with over 700 active investors. It has overseen £14 million worth of investment on its portal to date. Brickowner will use the investment towards technology up-gradation, hire strategic personnel to expand marketing, and increase its marketing spend.
days to go:
Expired
investment:
£132,528
Aiming to prevent further deterioration and leakage of water and sewerage pipes, Aqualiner has developed their Melt in Place Pipe (MIPP). This patented technology consists of a sock insertion, which when heated, expands and melts onto the inner pipe and forms a solid glass-reinforced thermoplastic layer. This process can increase the longevity of existing pipes and is the only product of this type to be approved to be safe-for-use in drinking water pipes. The UK has more than 251,000 miles of water pipes, where almost 75,000 miles of pipes are classed as damaged.
Aqualiner firstly plans to sell the initial equipment in return for a small profit margin, but the materials and consumables used in the process will be sold to the licensed contractor directly as a second income stream. The third source of revenue is derived from fees charged to International territorial licensors for any Aqualiner sales.
The product has been developed with support from Anglian Water, Severn Trent Water and Yorkshire Water and is approved to be installed in US drinking water pipes.
days to go:
Expired
investment:
£642,471
Zing Zing is revolutionising the £1.4bn Chinese takeout industry by offering Chinese cuisine with a modern and healthy twist, cooked fresh to order and delivered fast.Having grown from 2 sites to 4 since their last round on Crowdcube.
days to go:
Expired
investment:
£1,163,950
West Berkshire Brewery (WBB) have been brewing cask ales and bottled beers since 1995 and have won more than 40 awards. WBB use locally sourced ingredients and are trying to make their business as sustainable as possible.
days to go:
Expired
investment:
£1,765,482
